Regulation of p53 protein function through alterations in protein-folding pathways

Cellular and Molecular Life Sciences

Volumn 55, Issue 1, 1999, Pages 88-95

  Hupp, T R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Heat shock proteins; Oligomerization; p53; Phosphorylation; Protein folding

Indexed keywords

PROTEIN P53; TETRAMER; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DNA BINDING; MISSENSE MUTATION; POINT MUTATION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANTIGENS, VIRAL, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; MOLECULAR CHAPERONES; PHOSPHORYLATION; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032988319     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050272     Document Type: Review

References (77)

1. 1 Avantaggiati M. L., Ogryzko V., Gardner K., Giordano A., Levine A. S. and Kelly K. (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184
2. 2 Lill N. L., Grossman S. R., Ginsberg D., DeCaprio J. and Livingston D. M. (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827
3. 3 Thut C. J., Chen J. L., Klemm R. and Tjian R. (1994) p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267: 100-104
4. 4 Garkavtsev I., Grigorian I. A., Ossovskaya V. S., Chernov M. V., Chumakov P. M. and Gudkov A. V. (1998) The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391: 295-298
5. 5 Haupt Y., Maya R., Kazaz A. and Oren M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
6. 6 Kubbutat M. H., Jones S. N. and Vousden K. H. (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
7. 7 Stenger J. E., Mayr G. A., Mann K. and Tegtmeyer P. (1992) Formation of stable p53 homotetramers and multiples of tetramers. Mol. Carcinog. 5: 102-106
8. 8 Friedman P. N., Chen X., Bargonetti J. and Prives C. (1993) The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl. Acad. Sci. USA 90: 3319-3323
9. 9 El-Deiry W. S., Kern S. E., Pietenpol J. A., Kinzler K. W. and Vogelstein B. (1992) Definition of a consensus binding site for p53. Nature Genet. 1: 45-49
10. 10 Wang Y., Schwedes J. F., Parks D., Mann K. and Tegtmeyer P. (1995) Interaction of p53 with its consensus DNA-binding site. Mol. Cell. Biol. 15: 2157-2165
11. 11 El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
12. 12 Kastan M. B., Zhan Q., el-Deiry W. S., Carrier F., Jacks T., Walsh W. V. et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 s defective in ataxiatelangiectasia. Cell 71: 587-597
13. 13 Momand J., Zambetti G. P., Olson D. C., George D. and Levine A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245
14. 14 Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B. R. et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649
15. 15 Miyashita T. and Reed J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
16. 16 Hartwell L. H. and Kastan M. B. (1994) Cell cycle control and cancer. Science 266: 1821-1828
17. 17 Tokino T., Thiagalingam S., el-Deiry W. S., Waldman T., Kinzler K. W. and Vogelstein B. (1994) p53 tagged sites from human genomic DNA. Hum. Mol. Genet. 3: 1537-1542
18. 18 Polyak K., Xia Y., Zweier J. L., Kinzler K. W. and Vogelstein B. (1997) A model for p53-induced apoptosis. Nature 389: 300-305
19. 19 Wyllie A. (1997) Apoptosis. Clues in the p53 murder mystery. Nature 389: 237-238
20. 20 Bourdon J. C., Deguin-Chambon V., Lelong J. C., Dessen P., May P., Debuire B. et al. (1997) Further characterisation of the p53 responsive element-identification of new candidate genes for trans-activation by p53. Oncogene 14: 85-94
21. 21 Stenger J. E., Tegtmeyer P., Mayr G. A., Reed M., Wang Y., Wang P. et al. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J. 13: 6011-6020
22. 22 Palecek E., Vlk D., Stankova V., Brazda V., Vojtesek B., Hupp T. R. et al. (1997) Tumor suppressor protein p53 binds preferentially to supercoiled DNA. Oncogene 15: 2201-2209
23. 23 Foord O. S., Bhattacharya P., Reich Z and Rotter V. (1991) A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res. 19: 5191-5198
24. 24 Oberosler P., Hloch P., Ramsperger U. and Stahl H. (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12: 2389-2396
25. 25 Nedbal W., Frey M., Willemann B., Zentgraf H. and Sczakiel G. (1997) Mechanistic insights into p53-promoted RNA-RNA annealing. J. Mol. Biol. 266: 677-687
26. 26 Reed M., Woelker B., Wang P., Wang Y., Anderson M. E. and Tegtmeyer P. (1995) The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92: 9455-9459
27. 27 Lee S., Elenbaas B., Levine A. and Griffith J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013-1020
28. 28 Lee S., Cavallo L. and Griffith J. (1997) Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272: 7532-7539
29. 29 Clore G. M., Ernst J., Clubb R., Omichinski J. G., Kennedy W. M., Sakaguchi K. et al. (1995) Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nature Struct. Biol. 2: 321-333
30. 30 Jeffrey P. D., Gorina S. and Pavletich N. P. (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267: 1498-1502
31. 31 Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
32. 32 Schmale H. and Bamberger C. (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene 15: 1363-1367
33. 33 Pietenpol J. A., Tokino T., Thiagalingam S., el-Deiry W. S., Kinzler K. W. and Vogelstein B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91: 1998-2002
34. 34 Waterman J. L., Shenk J. L. and Halazonetis T. D. (1995) The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J. 14: 512-519
35. 35 McCoy M., Stavridi E. S., Waterman J. L., Wieczorek A. M., Opella S. J. and Halazonetis T. D. (1997) Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain. EMBO J. 16: 6230-6236
36. 36 Hupp T. R., Sparks A. and Lane D. P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237-245
37. 37 Hupp T. R., Meek D. W., Midgley C. A. and Lane D. P. (1993) Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21: 3167-3174
38. 38 Hupp T. R. and Lane D. P. (1994) Allosteric activation of latent p53 tetramers. Curr. Biol. 4: 865-875
39. 39 Wang Y. and Prives C. (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91
40. 40 Sakaguchi K., Sakamoto H., Lewis M. S., Anderson C. W., Erickson J. W., Appella E. et al. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36: 10117-10124
41. 41 Hupp T. R., Meek D. W., Midgley C. A. and Lane D. P. (1992) Regulation of the specific DNA binding function of p53. Cell 71: 875-886
42. 42 Hansen S., Midgley C. A., Lane D. P., Freeman B. C., Morimoto R. I. and Hupp T. R. (1996) Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70. J. Biol. Chem. 271: 30922-30928
43. 43 Barak Y., Juven T., Haffner R. and Oren M. (1997) mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468
44. 44 Hansen S., Hupp T. R. and Lane D. P. (1996) Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. J. Biol. Chem. 271: 3917-3924
45. 45 Friedlander P., Legros Y., Soussi T. and Prives C. (1996) Regulation of mutant p53 temperature-sensitive DNA binding. J. Biol. Chem. 271: 25468-25478
46. 46 Jayaraman L., Freulich E. and Prives C. (1997) Functional dissection of p53 tumor suppressor protein. Methods Enzymol. 283: 245-256
47. 47 Pinhasi-Kimhi O., Michalovitz D., Ben-Zeev A. and Oren M. (1986) Specific interaction between the p53 cellular tumour antigen and major heat shock proteins. Nature 320: 182-184
48. 48 Sugito K., Yamane M., Hattori H., Hayashi Y., Tohnai I., Ueda M. et al. (1995) Interaction between hsp70 and hsp40. eukaryotic homologues of DnaK and DnaJ, in human cells expressing mutant-type p53. FFBS Lett. 358: 161-164
49. 49 Sepehrnia B., Paz I. B., Dasgupta G. and Momand J. (1996) Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J. Biol. Chem. 271: 15084-15090
50. 50 Freeman B. C. and Morimoto R. I. (1996) The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J. 15: 2969-2979
51. 51 Gordon S. A., Hoffman R. A., Simmons R. L. and Ford H. R. (1997) Induction of heat shock protein 70 protects thymocytes against radiation-induced apoptosis. Arch. Surg. 132: 1277-1282
52. 52 Mehlen P., Schulze-Osthoff K. and Arrigo A. P. (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1-and staurosporine-induced cell death. J. Biol. Chem. 271: 16510-16514
53. 53 Polla B. S., Kantengwa S., Francois D., Salvioli S., Franceschi C., Marsac C. et al. (1996) Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc. Natl. Acad. Sci. USA 93: 6458-6463
54. 54 Li W. X., Chen C. H., Ling C. C. and Li G. C. (1996) Apoptosis in heat-induced cell killing: the protective role of hsp-70 and the sensitization effect of the c-myc gene. Radiat. Res. 145: 324-330
55. 55 Gannon J. V., Greaves R., Iggo R. and Lane D. P. (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9: 1595-1602
56. 56 Fourie A. M., Hupp T. R., Lane D. P., Sang B. C., Barbosa M. S., Sambrook J. F. et al. (1997) HSP70 binding sites in the tumor suppressor protein p53. J. Biol. Chem. 272: 19471-19479
57. 57 Vojtesek B. and Lane D. P. (1993) Regulation of p53 protein expression in human breast cancer cell lines. J. Cell Sci. 105: 607-612
58. 58 Bullock A. N., Henckel J., DeDecker B. S., Johnson C. M., Nikolova P. V., Proctor M. R. et al. (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl. Acad. Sci. USA 94: 14338-14342
59. 59 Brown C. R., Hong-Brown L. Q. and Welch W. J. (1997) Correcting temperature-sensitive protein folding defects. J. Clin. Invest. 99: 1432-1444
60. 60 DeBoer C., Meulman P. A., Wnuk R. J. and Peterson D. H. (1970) Geldanamycin, a new antibiotic. J. Antibiot. (Tokyo) 23: 442-447
61. 61 Schulte T. W., Blagosklonny M. V., Ingui C. and Neckers L. (1995) Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J. Biol. Chem. 270: 24585-24588
62. 62 An W. G., Schnur R. C., Neckers L. and Blagosklonny M. V. (1997) Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity. Cancer Chemother. Pharmacol. 40: 60-64
63. 63 Stebbins C. E., Russo A. A., Schneider C., Rosen N., Hartl F. U. and Pavletich N. P. (1997) Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89: 239-250
64. 64 Blagosklonny M. V., Toretsky J. and Neckers L. (1995) Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene 11: 933-939
65. 65 Whitesell L., Sutphin P., An W. G., Schulte T., Blagosklonny M. V. et al. (1997) Geldanamycin stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene 14: 2809-2816
66. 66 Blagosklonny M. V., Toretsky J., Bohen S. and Neckers L. (1996) Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl. Acad. Sci. USA 93: 8379-8383
67. 67 Lane D. P. and Crawford L. V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261-263
68. 68 Linzer D. I. and Levine A. J. (1979) Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43-52
69. 69 DeCaprio J. A., Ludlow J. W., Figge J., Shew J. Y., Huang C. M., Lee W. H. et al. (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275-283
70. 70 Eckner R., Ludlow J. W., Lill N. L., Oldread E., Arany Z., Modjtahedi N. et al. (1996) Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16: 3454-3464
71. 71 Kelley W. L. and Georgopoulos C. (1997) The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. Proc. Natl. Acad. Sci. USA 94: 3679-3684
72. 72 Srinivasan A., McClellan A. J., Vartikar J., Marks I., Cantalupo P., Li Y. et al. (1997) The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol. Cell. Biol. 17: 4761-4773
73. 73 Kernohan N. M., Hupp T. R. and Lane D. P. (1996) Modification of an N-terminal regulatory domain of T antigen restores p53-T antigen complex formation in the absence of an essential metal ion cofactor. J. Biol. Chem. 271: 4954-4960
74. 74 Sheng Q., Denis D., Ratnofsky M., Roberts T. M., DeCaprio J. A. and Schaffhausen B. (1997) The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function. J. Virol. 71: 9410-9416
75. 75 Selivanova G., Iotsova V., Okan I., Fritsche M., Strom M., Groner B. et al. (1997) Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nature Med. 3: 632-638
76. 76 Hupp T. R. and Lane D. P. (1995) Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J. Biol. Chem. 270: 18165-18174
77. 77 Wagner P., Fuchs A., Gotz C., Nastainczyk W. and Montenarh M. (1998) Fine mapping and regulation of the association of p53 with p34CDC2. Oncogene 16: 105-111